198 related articles for article (PubMed ID: 17017971)
21. Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands.
Szalata C; Szymoniak J; Fabis F; Butt-Gueulle S; Rault S; Bertus P; Gérard S; Sapi J
ChemMedChem; 2013 Jan; 8(1):70-3. PubMed ID: 23129513
[TBL] [Abstract][Full Text] [Related]
22. Chemical update on the potential for serotonin 5-HT
Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
[TBL] [Abstract][Full Text] [Related]
23. Review of 5-HT4R ligands: state of art and clinical applications.
Bureau R; Boulouard M; Dauphin F; Lezoualc'h F; Rault S
Curr Top Med Chem; 2010; 10(5):527-53. PubMed ID: 20166943
[TBL] [Abstract][Full Text] [Related]
24. 5-hydroxytryptamine (5-HT) receptor ligands.
Kitson SL
Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
[TBL] [Abstract][Full Text] [Related]
25. 5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity.
Kim Y; Park H; Lee J; Tae J; Kim HJ; Min SJ; Rhim H; Choo H
Eur J Med Chem; 2016 Nov; 123():180-190. PubMed ID: 27475109
[TBL] [Abstract][Full Text] [Related]
26. The 5-HT1A receptor and its ligands: structure and function.
Olivier B; Soudijn W; van Wijngaarden I
Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology and Therapeutic Potential of the 5-HT
Blattner KM; Canney DJ; Pippin DA; Blass BE
ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
[TBL] [Abstract][Full Text] [Related]
28. Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions.
Russell MG; Dias R
Curr Top Med Chem; 2002 Jun; 2(6):643-54. PubMed ID: 12052198
[TBL] [Abstract][Full Text] [Related]
29. Role of spinal 5-HT5A, and 5-HT1A/1B/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats.
Avila-Rojas SH; Velázquez-Lagunas I; Salinas-Abarca AB; Barragán-Iglesias P; Pineda-Farias JB; Granados-Soto V
Brain Res; 2015 Oct; 1622():377-85. PubMed ID: 26168890
[TBL] [Abstract][Full Text] [Related]
30. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.
Moritomo A; Yamada H; Watanabe T; Itahana H; Akuzawa S; Okada M; Ohta M
Bioorg Med Chem; 2013 Dec; 21(24):7841-52. PubMed ID: 24189186
[TBL] [Abstract][Full Text] [Related]
32. Emerging opportunities and concerns for drug discovery at serotonin 5-HT2B receptors.
Brea J; Castro-Palomino J; Yeste S; Cubero E; Párraga A; Domínguez E; Loza MI
Curr Top Med Chem; 2010; 10(5):493-503. PubMed ID: 20166944
[TBL] [Abstract][Full Text] [Related]
33. Novel discriminatory ligands for 5-HT2B receptors.
Baxter GS
Behav Brain Res; 1996; 73(1-2):149-52. PubMed ID: 8788493
[TBL] [Abstract][Full Text] [Related]
34. Chronic 5-HT
García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
[TBL] [Abstract][Full Text] [Related]
35. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
36. 5-HT2 receptor subtypes: a family re-united?
Baxter G; Kennett G; Blaney F; Blackburn T
Trends Pharmacol Sci; 1995 Mar; 16(3):105-10. PubMed ID: 7792930
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.
Zhang D; Kohlman D; Krushinski J; Liang S; Ying BP; Reilly JE; Dinn SR; Wainscott DB; Nutter S; Gough W; Nelson DL; Schaus JM; Xu YC
Bioorg Med Chem Lett; 2004 Dec; 14(24):6011-6. PubMed ID: 15546719
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
[TBL] [Abstract][Full Text] [Related]
39. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
40. The computer-aided discovery of novel family of the 5-HT
Łażewska D; Kurczab R; Więcek M; Kamińska K; Satała G; Jastrzębska-Więsek M; Partyka A; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2017 Jul; 135():117-124. PubMed ID: 28441580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
